Anaptysbio (ANAB) Return on Capital Employed Growth (5y) (2022 - 2026)
Anaptysbio (ANAB) Return on Capital Employed Growth (5y) (2022 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Anaptysbio | 1.54 Bn | 1.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,152.00 |
| Dec 31, 2025 | 2,123.00 |
| Sep 30, 2025 | 1,218.00 |
| Jun 30, 2025 | -248.00 |
| Mar 31, 2025 | -167.00 |
| Dec 31, 2024 | 3.00 |
| Sep 30, 2024 | -1,135.00 |
| Jun 30, 2024 | -2,390.00 |
| Mar 31, 2024 | -2,500.00 |
| Dec 31, 2023 | -2,452.00 |
| Sep 30, 2023 | -1,825.00 |
| Jun 30, 2023 | -1,263.00 |
| Mar 31, 2023 | -1,221.00 |
| Dec 31, 2022 | -597.00 |
| Sep 30, 2022 | 118.00 |
| Jun 30, 2022 | -248.00 |
| Mar 31, 2022 | 199.00 |